- Oura pushes deeper into healthcare services as part of new ring launchAlongside the debut of Oura's smaller Ring 5, the wearables company on Thursday unveiled its plans to help users integrate health records and translate their ring’s findings into medical care. Ou…Endpoints · 1mo ago↗ source
- AbbVie clinches FDA approval for ultra-rare blood cancer ADC from ImmunoGen purchaseAbbVie said the FDA has approved an antibody-drug conjugate it obtained as part of its $10.1 billion buyout of ImmunoGen for an ultra-rare but aggressive form of blood cancer. On Wednesday, the ...Endpoints · 1mo ago↗ source
- GSK spells out positive Phase 3 data for hepatitis B drug it licensed from IonisGSK has shared detailed results from a pair of late-stage trials testing a chronic hepatitis B treatment originally developed by Ionis Pharmaceuticals, with regulatory reviews underway in four mark…